> top > docs > PMC:7205724 > spans > 348-732 > annotations

PMC:7205724 / 348-732 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
7 66-74 Disease denotes COVID-19 MESH:C000657245
10 79-82 Gene denotes IL6 Gene:3569
11 151-159 Disease denotes COVID-19 MESH:C000657245
17 185-188 Gene denotes IL6 Gene:3569
18 244-247 Gene denotes IL6 Gene:3569
19 212-220 Species denotes patients Tax:9606
20 164-175 Chemical denotes Tocilizumab MESH:C502936
21 226-234 Disease denotes COVID-19 MESH:C000657245
53 263-280 Species denotes novel coronavirus Tax:2697049
54 282-291 Species denotes SARS-CoV2 Tax:2697049
55 345-351 Species denotes humans Tax:9606
65 317-330 Disease denotes fatal disease MESH:D034062
66 332-340 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 66-74 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 151-159 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 226-234 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 282-286 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T7 332-340 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 303-304 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 345-351 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T5 46-61 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 122-132 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T2 323-330 http://purl.obolibrary.org/obo/OGMS_0000031 denotes disease

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 46-61 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T3 66-74 Species denotes COVID-19 NCBItxid:2697049
T4 151-159 Species denotes COVID-19 NCBItxid:2697049
T5 226-234 Species denotes COVID-19 NCBItxid:2697049
T6 282-291 Species denotes SARS-CoV2 NCBItxid:2697049
T7 332-340 Species denotes COVID-19 NCBItxid:2697049
T8 345-351 Species denotes humans NCBItxid:9605

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T8 76-160 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 161-248 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 250-258 Sentence denotes Abstract
T11 259-352 Sentence denotes The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
7 66-74 Disease denotes COVID-19 MESH:C000657245
10 79-82 Gene denotes IL6 Gene:3569
11 151-159 Disease denotes COVID-19 MESH:C000657245
20 164-175 Chemical denotes Tocilizumab MESH:C502936
17 185-188 Gene denotes IL6 Gene:3569
19 212-220 Species denotes patients Tax:9606
21 226-234 Disease denotes COVID-19 MESH:C000657245
18 244-247 Gene denotes IL6 Gene:3569
53 263-280 Species denotes novel coronavirus Tax:2697049
54 282-291 Species denotes SARS-CoV2 Tax:2697049
65 317-330 Disease denotes fatal disease MESH:D034062
66 332-340 Disease denotes COVID-19 MESH:C000657245
55 345-351 Species denotes humans Tax:9606

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 79-82 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T45 185-188 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 244-247 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T50 10-18 JJ denotes clinical
T51 19-25 NNS denotes trials
T52 26-31 VBP denotes exist
T53 32-34 IN denotes on
T54 35-38 DT denotes the
T55 39-42 NN denotes use
T56 43-45 IN denotes of
T57 46-61 NNS denotes corticosteroids
T58 62-65 IN denotes for
T59 66-74 NN denotes COVID-19
T60 76-77 LS denotes •
T61 79-82 NN denotes IL6
T62 83-93 VBZ denotes correlates
T63 94-98 IN denotes with
T64 99-107 NN denotes severity
T65 107-108 -COMMA- denotes ,
T66 109-120 NN denotes criticality
T67 120-121 -COMMA- denotes ,
T68 122-127 JJ denotes viral
T69 128-132 NN denotes load
T70 132-133 -COMMA- denotes ,
T71 134-137 CC denotes and
T72 138-147 NN denotes prognosis
T73 148-150 IN denotes of
T74 151-159 NN denotes COVID-19
T75 161-162 IN denotes •
T76 164-175 NNP denotes Tocilizumab
T77 175-176 -COMMA- denotes ,
T78 177-179 DT denotes an
T79 180-188 NN denotes anti-IL6
T80 188-189 -COMMA- denotes ,
T81 190-193 MD denotes can
T82 194-200 VB denotes confer
T83 201-208 NN denotes benefit
T84 209-211 IN denotes in
T85 212-220 NNS denotes patients
T86 221-225 IN denotes with
T87 226-234 NN denotes COVID-19
T88 235-238 CC denotes and
T89 239-243 JJ denotes high
T90 244-247 NN denotes IL6
T91 250-258 NN denotes Abstract
T92 259-262 DT denotes The
T93 263-268 JJ denotes novel
T94 269-280 NN denotes coronavirus
T95 280-281 -COMMA- denotes ,
T96 282-291 NN denotes SARS-CoV2
T97 291-292 -COMMA- denotes ,
T98 293-296 MD denotes can
T99 297-302 VB denotes cause
T100 303-304 DT denotes a
T101 305-316 RB denotes potentially
T102 317-322 JJ denotes fatal
T103 323-330 NN denotes disease
T104 330-331 -COMMA- denotes ,
T105 332-340 NN denotes COVID-19
T106 340-341 -COMMA- denotes ,
T107 342-344 IN denotes in
T108 345-351 NNS denotes humans
T109 353-357 RB denotes Here
T110 357-358 -COMMA- denotes ,
T111 359-361 PRP denotes we
T112 362-366 MD denotes will
T113 367-374 VB denotes provide
T114 375-377 DT denotes an
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high
R85 T94 T92 arg1Of coronavirus,The
R86 T94 T93 arg1Of coronavirus,novel
R87 T94 T95 arg1Of coronavirus,","
R88 T96 T95 arg2Of SARS-CoV2,","
R89 T99 T97 arg1Of cause,","
R90 T94 T98 arg1Of coronavirus,can
R91 T99 T98 arg2Of cause,can
R92 T94 T99 arg1Of coronavirus,cause
R93 T103 T99 arg2Of disease,cause
R94 T103 T100 arg1Of disease,a
R95 T102 T101 arg1Of fatal,potentially
R96 T103 T102 arg1Of disease,fatal
R97 T103 T104 arg1Of disease,","
R98 T105 T104 arg2Of COVID-19,","
R99 T99 T106 arg1Of cause,","
R100 T99 T107 arg1Of cause,in
R101 T108 T107 arg2Of humans,in
R102 T113 T109 arg1Of provide,Here
R103 T113 T110 arg1Of provide,","
R104 T111 T112 arg1Of we,will
R105 T113 T112 arg2Of provide,will
R106 T111 T113 arg1Of we,provide

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 66-74 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 151-159 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 226-234 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 282-291 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T7 332-340 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T8 76-160 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 161-248 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 250-258 Sentence denotes Abstract
T11 259-352 Sentence denotes The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans.